CN Patent

CN1845938B — 多肽

Assigned to Domantis Ltd · Expires 2010-05-26 · 16y expired

What this patent protects

本发明包括含有一个或多个抗体结构域的天然发生的，或合成的聚合物连接的多肽。

USPTO Abstract

本发明包括含有一个或多个抗体结构域的天然发生的，或合成的聚合物连接的多肽。

Drugs covered by this patent

dabigatran-etexilate-mesylate (DABIGATRAN ETEXILATE MESYLATE)

Patent Metadata

Patent number: CN1845938B
Jurisdiction: CN
Classification: —
Expires: 2010-05-26
Drug substance claim: No
Drug product claim: No
Assignee: Domantis Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.